Emerging roles of the complement system in host–pathogen interactions
SK Sahu, DH Kulkarni, AN Ozanturk, L Ma… - Trends in …, 2022 - cell.com
The complement system has historically been entertained as a fluid-phase, hepatically
derived system which protects the intravascular space from encapsulated bacteria …
derived system which protects the intravascular space from encapsulated bacteria …
The complement system testing in clinical laboratory
X Ding, A Qamar, H Liu - Clinica Chimica Acta, 2023 - Elsevier
With the advancement in research in the field of the complement system, a more
comprehensive understanding developed about the complement system's role in the life …
comprehensive understanding developed about the complement system's role in the life …
[HTML][HTML] Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis
Background & Aims Cirrhosis-associated immune dysfunction (CAID) affects both innate and
adaptive immunity. This study investigated the complement system, immunoglobulins, and …
adaptive immunity. This study investigated the complement system, immunoglobulins, and …
[HTML][HTML] Mannan-binding lectin via interaction with cell surface calreticulin promotes senescence of activated hepatic stellate cells to limit liver fibrosis progression
J Luo, L Li, B Chang, Z Zhu, F Deng, M Hu, Y Yu… - Cellular and Molecular …, 2022 - Elsevier
Background & Aims Liver fibrosis represents a hallmark of most chronic liver diseases (CLD)
triggered by recurrent liver injury and subsequent myofibroblast transdifferentiations of …
triggered by recurrent liver injury and subsequent myofibroblast transdifferentiations of …
Diagnostic and prognostic significance of complement in patients with alcohol‐associated hepatitis
Background and Aims Given the lack of effective therapies and high mortality in acute
alcohol‐associated hepatitis (AH), it is important to develop rationally designed biomarkers …
alcohol‐associated hepatitis (AH), it is important to develop rationally designed biomarkers …
Immunoglobulin A and complement C4 are involved in the progression of liver fibrosis in patients with chronic hepatitis B
X Zhang, Z Wan, M Lin, Y Li, X Wu, J Jiang, S Lin… - International …, 2023 - Elsevier
Objective To explore the relationship between immunoglobulin A (IgA), complement C4, and
liver fibrosis (LF) progression (LFP) in patients with chronic hepatitis B (CHB). Methods This …
liver fibrosis (LF) progression (LFP) in patients with chronic hepatitis B (CHB). Methods This …
[HTML][HTML] The complement system in liver diseases: Evidence-based approach and therapeutic options
T Lung, B Sakem, L Risch, R Würzner, G Colucci… - Journal of translational …, 2019 - Elsevier
Complement is usually seen to largely originate from the liver to accomplish its tasks
systemically–its return to the production site has long been underestimated. Recent …
systemically–its return to the production site has long been underestimated. Recent …
Increased ferritin levels in non‐transfusion‐dependent β°‐thalassaemia/HbE are associated with reduced CXCR2 expression and neutrophil migration
C Thiengtavor, S Siriworadetkun… - British Journal of …, 2020 - Wiley Online Library
Severe bacterial infection is a major complication causing morbidity and mortality in β‐
thalassaemia/HbE patients. Innate immunity constitutes the first line of defence against …
thalassaemia/HbE patients. Innate immunity constitutes the first line of defence against …
[HTML][HTML] Human Amnion-Derived Mesenchymal Stromal Cells: A New Potential Treatment for Carbapenem-Resistant Enterobacterales in Decompensated Cirrhosis
M Pampalone, G Vitale, S Gruttadauria… - International Journal of …, 2022 - mdpi.com
Background: Spontaneous bacterial peritonitis (SBP) is a severe and often fatal infection in
patients with decompensated cirrhosis and ascites. The only cure for SBP is antibiotic …
patients with decompensated cirrhosis and ascites. The only cure for SBP is antibiotic …
[HTML][HTML] A novel noninvasive diagnostic model of HBV-related inflammation in chronic hepatitis B virus infection patients with concurrent nonalcoholic fatty liver …
X Tao, L Chen, Y Zhao, Y Liu, R Shi, B Jiang… - Frontiers in …, 2022 - frontiersin.org
Background and Aims Patients with chronic hepatitis B virus infection (CBI) with concurrent
nonalcoholic fatty liver disease (NAFLD) is becoming increasingly common in clinical …
nonalcoholic fatty liver disease (NAFLD) is becoming increasingly common in clinical …